Shrier Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Buy
22,112
+177
+0.8% +$20.7K 0.96% 30
2026
Q1
$2.64M Sell
21,935
-192
-0.9% -$22.2K 0.96% 29
2025
Q4
$2.33M Buy
+22,127
New +$2.08M 0.92% 33

Other funds holding MRK

Shrier Wealth Management's MRK Position: Q2 2026 in Review

Shrier Wealth Management increased its Merck (MRK) stake by 0.81% in Q2 2026, buying an estimated $20.7K and bringing the position to 22,112 shares worth $2.84M. The position accounts for 0.96% of the portfolio, ranked #30.

Shrier Wealth Management first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Shrier Wealth Management held 22,112 shares of Merck worth $2.84M as of Q2 2026.
  • Shrier Wealth Management bought 177 Merck shares in Q2 2026, an estimated $20.7K.
  • Merck made up 0.96% of Shrier Wealth Management's portfolio in Q2 2026, its #30 holding.
  • Shrier Wealth Management first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,814 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Shrier Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.